Here is my latest work on managing a pandemic

1. RACE TO COVID19 VACCINE AND TESTING
PAUL YOUNG CPA CGA
DECEMBER 30, 2020

2. PAUL YOUNG - BIO
• CPA, CGA
• Academia (PF1, FA4 and MS2)
• SME – Risk Management
• SME – Close, Consolidate and Reporting
• SME – Public Policy
• SME – Emerging Technology
• SME – Business Process Change
• SME – Financial Solutions
• SME – Supply Chain Management
Contact information:
Paul_Young_CGA@Hotmail.com

3. INTRODUCTION
This presentation looks at what is happening with the COVID19 vaccine development.

4. AGENDA
 Pharma and Vaccines
development
 Key Companies
 CANSINO BIOLOGICS
 Symvivio Corporation
 Novovax
 CureVac
 Generex
 Vaxart
 Medicago
 Takis
 Altimmune
 Testing
 Testing Kits
 Global Market / Testing
 Effective Treatments
• Antibodies
• Mitigation
• Contact Tracing
• Medical Equipment and
Supplies
• Justin Trudeau Management
• Donald Trump and
Pandemic
• WHO
• CDC and Deaths
• Canada Monitoring
• Lockdowns
• Variations of Coronaviruses
• Travel
• Fiscal Management/Canada
• Reforming Healthcare
• GDP
• Cases/Deaths
• Storage
• Vaccine Production
• Testing /Mitigation
• Vaccine Tracking
• Vaccines Rollout
• Summary

5. MAJOR PLAYERS / VACCINES DEVELOPMENT

6. FINANCIAL PERFORMANCE KEY COMPANIES

7. CANSINO
BIOLOGICS
INC.(6185)
 100% of the revenue is in China -
https://www.marketscreener.com/CANSINO-BIOLOGICS-INC-
59318312/company/
 The chair is McGill graduate. https://www.marketscreener.com/business-
leaders/Xue-Feng-Yu-0DD2L9-E/biography/ Trudeau attended McGill and
McGill has high Chinese enrolment -
https://www.mcgill.ca/international/channels/news/mcgill-news-china-
tops-international-enrolment-mcgill-first-time-291377
 J&J and Casino have similar vaccine -
https://www.reuters.com/article/health-coronavirus-vaccine/special-
report-countries-companies-risk-billions-in-race-for-coronavirus-
vaccine-idUSL2N2CF0JG. China is ahead of the curve. China weakness has
always been with real facts.
 https://www.fiercepharma.com/vaccines/china-s-cansino-pushes-
coronavirus-vaccine-into-clinical-testing-as-moderna-doses-1st “The
green light was doled out very quickly. It was only Tuesday when CanSino
said it had filed the pre-IND review application for the vaccine to
authorities and was in the process of a rolling submission of technical
documents. CanSino’s candidate, dubbed Ad5-nCoV, uses its adenovirus-
based viral vector vaccine platform. In 2017, the same technology helped
the company earn a Chinese nod for its Ebola vaccine, which was the first
Ebola shot approved anywhere based on the strain behind the deadly
epidemic in West Africa in 2014.
 Trial of COVID19 drug back by the Military -
https://twitter.com/dockaurg/status/1262018934569664515
 Last 10K filed was 2017 - https://fintel.io/filings/us/casbf
 Only 2018 showed revenue

8. SYMVIVIO
CORPORATION
 Early VC company working with Canadian government -
https://pitchbook.com/profiles/company/185411-98#funding (Key investor -
National Research Council Canada
 https://www.dnb.com/business-directory/company-
profiles.symvivo_corporation.31108ce6e17eb52f4e64c097dc36f2f7.html
“Symvivo Corporation is in Burnaby, BC, Canada and is part of the
Biotechnology Research Services Industry. Symvivo Corporation has 3 total
employees across all of its locations and generates $580,698 in sales (USD).”
 Small venture capital and pre-trials - https://www.trialsitenews.com/ubc-
dalhousie-university-commence-study-of-the-bactrl-spike-vaccine-targeting-
covid-19/ “According to one profile, the venture has raised $2 million from a
local early state venture investor and $100K from a National Research Council.
Founder Graves started the company, along with Mark Fox—a friend from
undergrad—as he realized “he sucked” at research but desired to leverage his
scientific degree in meaningful ways. Graves and Fox sought to develop a
platform that could accelerate drug development by focusing on the
discovery—developing patents for aspects of the drug delivery process that
could be licensed to drug makers”

9. NOVOVAX
 A small group of scientists, execs, and VCs are $277 million richer as their companies
race to create a coronavirus vaccine. Here are 7 who have raked in huge sums. -
https://markets.businessinsider.com/news/stocks/coronavirus-drugmakers-moderna-
gilead-novavax-stock-price-profit-millions-shareholders-2020-2-1028949761
 Stock sales due to trials -
https://www.bizjournals.com/washington/news/2020/05/20/novavax-prepares-stock-
sale-as-covid-19-vaccine.html
 https://finance.yahoo.com/news/novavax-nvax-stock-come-too-224659672.html
“Vaccine specialist Novavax (NVAX) stepped up to the plate, and hit the ball out of
the park yet again. Investors had already enjoyed some pretty hefty gains in 2020
before more positive developments sent the stock into the stratosphere. Last week,
news that Novavax had received a $384 million grant from the Coalition for Epidemic
Preparedness Innovations (CEPI) to support the development of its COVID-19 vaccine
candidate, NVX-CoV2373, resulted in a 133% addition to the share price”
 Coalition Preparedness https://cepi.net/about/whoweare/ - CEPI has secured
financial investment from the Governments of Australia, Belgium, Canada,
Denmark, Ethiopia, Finland, Germany, Japan, the Kingdom of Saudi Arabia, the
Netherlands, Norway, the UK and Switzerland, as well as the Bill & Melinda
Gates Foundation, and Wellcome. The European Commission provides
substantial financial contributions to support relevant projects through its
mechanisms. CEPI has also received donations from the private sector and
individuals through the UN Foundation’s COVID-19 Solidarity Response Fund to
support our COVID-19 vaccine development efforts.

10. CUREVAC
 As the race to develop a coronavirus vaccine intensifies, one player—
German drugmaker CureVac—is backed by particularly deep pockets.
CureVac, which is in the headlines amid rumors that the U.S.
government offered funding to lure its research exclusively to
America, counts one of Germany’s richest entrepreneurs, Mexican
shopping mall tycoons and the Bill and Melinda Gates Foundation
among its investors.
https://www.forbes.com/sites/martaorosz/2020/03/16/these-are-the-
billionaire-investors-behind-german-drugmakers-developing-a-
coronavirus-vaccine/#78c83f841fb8
 Regulators / Germany https://www.ft.com/content/7409dbae-6b4f-
4be0-ba75-46ed52e951ae
 In the race to find a medical breakthrough to the pandemic, the
startup, CureVac, said earlier this month that its proprietary
technology has found suitable candidates that could lead to a
treatment, and that it aims to start clinical trials in early summer.
CureVac has received funding from the Bill & Melinda Gates
Foundation. - https://fortune.com/2020/03/16/coronavirus-cure-
trump-businesses-biotech/

11. GENEREX
 Manufacturing of peptide -
https://www.globenewswire.com/news-
release/2020/05/04/2026744/0/en/Generex-Biotechnology-
Initiates-Peptide-Manufacturing-for-Ii-Key-SARS-CoV-2-Peptide-
Vaccine-Against-the-COVID-19-Pandemic.html
 Stock/Generex- https://www.fool.com/investing/2020/05/17/is-
buying-a-basket-loaded-with-every-coronavirus-v.aspx “BIO, the
biggest trade group representing the biotechnology industry,
currently lists 28 companies that are actively involved in
developing COVID-19 vaccines. Here are the 21 of those
drugmakers that are publicly traded:”

12. VAXART
 SOUTH SAN FRANCISCO, Calif., May 20, 2020 (GLOBE NEWSWIRE) --
Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-
stage biotechnology company developing oral recombinant vaccines
that are administered by tablet rather than by injection, today
announced that it has selected its lead COVID-19 vaccine candidate
and has contracted with KindredBio to manufacture bulk vaccine
under cGMP to complement the manufacturing capacity of partner
Emergent BioSolutions https://www.globenewswire.com/news-
release/2020/05/20/2036357/0/en/Vaxart-Announces-Selection-of-
its-Oral-COVID-19-Vaccine-Lead-Candidate.html
 Funding issues - https://seekingalpha.com/article/4334623-vaxarts-
coronavirus-stock-bump-is-unlikely-to-continue-exit-now-be-long
 Cash on hand - https://www.fool.com/investing/2020/04/28/why-
vaxart-stock-slumped-today.aspx
 Partnerships - https://observer.com/2020/05/covid-19-vaccine-
moderna-results-new-progress/

13. MEDICAGO
 Quebec Funding -
https://www.canadianmanufacturing.com/research-and-
development/government-of-quebec-providing-7m-to-
medicagos-covid-19-vaccine-development-249412/
 Animal Trials - https://www.sttinfo.fi/tiedote/medicago-
announces-positive-results-in-animal-trials-for-its-vaccine-
candidate-against-covid-
19?publisherId=58763726&releaseId=69881188
 Collaborative project of more than $1.2 million using artificial
intelligence to optimize the production of vaccines, announced
by CQDM and Medicago R&D - https://www.newswire.ca/news-
releases/collaborative-project-of-more-than-1-2-million-using-
artificial-intelligence-to-optimize-the-production-of-vaccines-
announced-by-cqdm-and-medicago-r-amp-d-859733879.html

14. TAKIS
 “TAKIS SRL is located in ROMA, ROMA, Italy and is part of the
Scientific Research & Development Services Industry. TAKIS SRL
has 15 employees at this location and generates $1.78 million in
sales (USD). There are 4 companies in the TAKIS SRL corporate
family. https://www.dnb.com/business-directory/company-
profiles.takis_srl.1084976c4f88cf6ddd4089044968c511.html
 Startup -
https://www.forbes.com/sites/giacomotognini/2020/04/21/inside
-the-tiny-italian-biotech-startup-racing-to-develop-a-
coronavirus-vaccine/#b686e172c106
 Funding - https://finance.yahoo.com/news/applied-dna-takis-
biotech-announce-070000273.html

15. UPDATE –
VACCINES /
DEVELOPMENT
Source - “”
https://www.healthline.com/healt
h-news/heres-exactly-where-
were-at-with-vaccines-and-
treatments-for-covid-19

16. VACCINES DEVELOPMENT
 GSK - https://indianexpress.com/article/coronavirus/coronavirus-covid-19-vaccine-glaxosmithkline-oxford-
astrazeneca-moderna-clover-status-check-6469474/
 Vaccine Tracker - https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
 Gavi organization funding from sources like Bill Gates and world governments - https://www.biopharma-
reporter.com/Article/2020/06/17/Gavi-receives-billions-in-funding
 Gates and Inovio - https://www.newsbreak.com/missouri/kansas-city/news/0OfXdfSR/a-potential-coronavirus-
vaccine-funded-by-bill-gates-is-set-to-begin-testing-in-people-with-the-first-patient-expected-to-get-it-
today

17. ALTIMUNE
 “Shares of Altimmune (ALT) - Get Report soared Thursday after
the clinical-stage biopharmaceutical company announced the
next step in development of its coronavirus vaccine AdCovid. “In
collaboration with the University of Alabama at Birmingham, we
have commenced preclinical testing of candidates for our Covid-
19 vaccine, AdCovid,” the company said in a statement.
https://www.thestreet.com/investing/altimmune-coronavirus-
vaccine-preclinical-trial
 Former Pfizer board director appointed to Altimmune -
https://www.reuters.com/companies/ALT.OQ

18. MODERNA
 Vaccine trials -
https://www.sciencemag.org/news/2020/11/absolutely-
remarkable-no-one-who-got-modernas-vaccine-trial-developed-
severe-covid-19
 Vaccine - https://www.modernatx.com/modernas-work-
potential-vaccine-against-covid-19
 Production - https://www.cnbc.com/2020/11/18/what-are-the-
big-challenges-to-mass-producing-a-coronavirus-vaccine.html

19. TESTING
 COVID19 – Testing “It uses a simple assay containing plasmonic gold
nanoparticles to detect a color change when the virus is present. The
test does not require the use of any advanced laboratory techniques,
such as those commonly used to amplify DNA, for analysis. The authors
published their work last week in the American Chemical Society’s
nanotechnology journal ACS Nano. "Based on our preliminary results,
we believe this promising new test may detect RNA material from the
virus as early as the first day of infection. Additional studies are needed,
however, to confirm whether this is indeed the case,” said study leader
Dipanjan Pan, PhD, professor of diagnostic radiology and nuclear
medicine and pediatrics at UMSOM.”
https://www.umaryland.edu/news/archived-news/may-2020/covid-19-
results-in-10-minutes-umb-studies-rapid-test.php or
https://www.nextbigfuture.com/2020/05/ten-minute-covid-19-
detection-test-using-
nanoparticles.html?utm_source=feedburner&utm_medium=feed&utm_
campaign=Feed%3A+blogspot%2Fadvancednano+%28nextbigfuture%
29

20. TESTING KITS
Source - https://www.medtechdive.com/news/coronavirus-tests-home-collection-quest-diagnostics-
letsgetchecked/578837/
The cost is $129 per kit!

21. GLOBAL MARKET / TESTING
Source - https://www.globenewswire.com/news-release/2020/06/01/2041269/0/en/Global-COVID-19-diagnostic-testing-market-to-amass-USD-44481-8-million-in-2020.html
• Additional costs to already strapped healthcare system
• Private insurance companies and their coverage in terms of their testing. This could mean a rise in premiums
• Consumers could be out of pocket about $129 per test.

22. TESTING ISSUES
Source - https://principia-scientific.com/who-finally-admits-covid19-pcr-test-has-a-problem/

23. TREATMENT OPTIONS

24. ANTIBODIES
 “Much remains to be learnt about the immunological responses to SARS-CoV-2. Nevertheless, it is becoming clear that antibodies taken from the
blood serum of people who have recovered from COVID-19 can be used for treatment by being transfused into other people who have the
disease”Source - https://www.nature.com/articles/d41586-020-01816-5
 Disappearance of antibodies 2-3 months - https://www.medscape.com/viewarticle/932671
 “Those who did not have a bad case of COVID-19 lose antibodies faster. Forty percent of asymptomatic individuals became seronegative and
12.9% of the symptomatic group became negative for IgG in the early convalescent phase. In addition, asymptomatic individuals exhibited lower
levels of 18 pro- and anti-inflammatory cytokines. These data suggest that asymptomatic individuals had a weaker immune response to SARS-
CoV-2 infection.mThe research, published in Nature Medicine on June 18, highlights the risks of using COVID-19 ‘immunity passports’ and
supports the prolonged use of public health interventions such as social distancing and isolating high-risk groups This seems to indicate that our
better bet is t-cell-related therapies and vaccines and hygiene and social distancing.
 Avoid getting together with larger groups
 Stay 6-10 ten feet apart if at all possible
 clean your hands every hour
 Source - https://www.nextbigfuture.com/2020/06/coronavirus-antibody-immunity-fades-by-70-within-2-3-
months.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2Fadvancednano+%28nextbigfuture%29

25. GENE RESEARCH
 Genome sequencing - https://globalnews.ca/news/7072424/alberta-researchers-genome-sequence-covid-19/
 AI and Genome sequencing - http://www.genomequebec.com/486-en/news-covid-19-unprecedented-
research-combining-genomics-and-artificial-intelligenceicial-intelligence/
 Blood type and genome - https://directorsblog.nih.gov/2020/06/18/genes-blood-type-tied-to-covid-19-risk-
of-severe-disease/

26. MITIGATION
 Shutting down an economy should be last resort
 Private sector is driven by cash flow.
 The focus should be on infrastructure, getting goods to market, supply chain, advance technology and reforming of government -
https://www.slideshare.net/paulyoungcga/canada-gdp-and-economy-truth-and-what-needs-to-change
 All levels of government should review their pandemic responses to ensure they have updated their playbook
 Annual audits of risk and crisis management should be completed each year - https://www.slideshare.net/paulyoungcga/the-role-of-operational-and-
performancebased-auditing-on-government-and-the-private-sector
 WHO needs to provide reports on virus threats including what needs to be done to mitigate the spread
 https://www.slideshare.net/paulyoungcga/crisis-management-how-best-to-managed-a-crisis
 More coordination by the WHO with all government including monthly status calls around threats
 Reporting should also be provided on the threats including performance audits of various WHO programs
 Mitigating the spread is to ensure healthcare is provided with the necessary equipment -
https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html
 Sterilization methods of equipment and masks - https://www.inthehammer.com/hamilton-firms-technology-addresses-covid-
waste-and-ppe-shortage
 Protecting the most vulnerable
 Screening at hospitals and long-term care facilities
 Restricting the movement of staff between facilities

27. UPDATE – JUNE 23, 2020 TO JULY 1, 2O20
 State of affairs with COVID19 - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-
and-treatments-for-covid-19
 Line is forming for the vaccine - https://www.sciencemag.org/news/2020/06/line-forming-covid-19-vaccine-who-
should-be-front
 You cannot shut down the economy, but all levels of government including the private sector need to take mitigating
steps - https://www.slideshare.net/paulyoungcga/transforming-the-economy-postcovid19-canada-and-the-world
 China is using the pandemic to make changes with laws for Hong Kong -
https://www.cnn.com/2020/07/01/asia/hong-kong-national-security-law-intl-hnk/index.html
 USA buys up key drug - https://globalnews.ca/news/7127951/us-remdesivir-supply-coronavirus/
 Antibody treatment - https://www.cnn.com/2020/06/26/health/antibody-therapies-covid-19-update-
wellness/index.html

28. VACCINES, HEALTH AND SAFETY AND TESTING UPDATE
 USA clinical trials - https://globalnews.ca/news/7178006/us-coronavirus-vaccine-testing/
 Human trials in Quebec - https://www.cbc.ca/news/health/human-trials-covid-19-vaccine-candidate-quebec-1.5648648
 World and treatment of COVID19 - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-treatments-for-covid-
19#Antivirals
 Vaccines Trials - https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
 Mobile testing kits - https://www.thestar.com/business/2020/07/09/guelph-companys-mobile-covid-19-test-kit-hits-market-and-heads-for-
norther-ontario.html
 Workplace measures - https://www.ontario.ca/page/develop-your-covid-19-workplace-safety-plan or http://www.worksafesask.ca/covid-
19/conducting-a-hazard-assessment-and-developing-a-safety-plan/
 Mobile workers - https://www.carsondesign.com/2017/12/designing-your-office-space-for-the-mobile-workforce/
 Vaccines trials - https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html or
https://newsinteractives.cbc.ca/coronavirusvaccinetracker/
 Government of Canada order doses - https://www.ctvnews.ca/canada/feds-order-supplies-to-give-two-doses-of-covid-19-vaccine-when-it-s-
ready-1.5029530
 Status of treatments and Vaccines – August 16, 2020 - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-
treatments-for-covid-19#Vaccines
 Treatments - https://catsroundtable.com/yale-prof-harvey-risch-hydroxychloroquine-hcq-covid-19/
 Vaccines and drugs - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-treatments-for-covid-19#Other-
treatments


29. CONTACT TRACING
 CDC – Close contact and airborne - https://www.triaxtec.com/blog/contact-tracing/cdc-guidelines-smartbrief/
 Development of contact tracing- “Contact tracing is the public health practice of informing people when they've been
exposed to a contagious disease. As it has become more widely employed across the U.S., it has also become mired in
modern political polarization and conspiracy theories.” - https://www.npr.org/sections/health-
shots/2020/07/14/890628203/conspiracy-theories-aside-heres-what-contact-tracers-really-do
 Privacy issues with contact tracing
 One of the biggest challenges, experts told a congressional panel this week, is dispelling the unease people feel about the government or private
companies gaining access to their personal data - https://www.marketwatch.com/story/us-contract-tracing-efforts-on-covid-19-falter-on-privacy-
worries-technology-gap-2020-07-09
 Data privacy laws like HIPAA, PIPDEA and EUGRP collide with contact tracing - https://www.reuters.com/article/bc-finreg-data-privacy-contact-
tracing/data-privacy-laws-collide-with-contact-tracing-efforts-privacy-is-prevailing-idUSKCN24M1NL
 There needs to be audits of the application on routine basis - https://priv.gc.ca/en/privacy-topics/health-genetic-and-other-body-
information/health-emergencies/rev_covid-app/ . All levels of government can automate the audit process through AI and Analytics -
https://www.slideshare.net/paulyoungcga/internal-audit-and-performance-base-auditing

30. MEDICAL SUPPLIES AND EQUIPMENT
 Companies continue to ramped up production of ventilators - https://www.globenewswire.com/news-
release/2020/07/22/2065727/0/en/191-Million-Worldwide-Ventilator-Test-Systems-Industry-to-2027-Impact-of-
COVID-19-on-the-Market.html
 Global Production - https://www.supplychainbrain.com/articles/31024-coronavirus-watch-governments-rush-to-
secure-ventilators
 Canada medical supplies and equipment
 https://www.tpsgc-pwgsc.gc.ca/comm/aic-scr/provisions-supplies-eng.html
 There needs to be an audit the readiness of medical supplies and equipment
 Liberals
 Masks production - https://torontosun.com/news/national/company-awarded-380m-in-contracts-but-fails-to-provide-masks-
blacklocks-reporter
 Ventilators - https://thepostmillennial.com/contract-awarded-to-former-liberal-mps-company-to-make-10-000-unapproved-
ventilators

31. JUSTIN TRUDEAU AND PANDEMIC MANAGEMENT
https://www.ctvnews.ca/health/coronavirus/the-fall-will-be-a-period-of-challenge-in-coronavirus-fight-canada-s-top-doctor-says-
1.5055678?taid=5f2e1fbcd7d51b0001834cab&utm_campaign=trueAnthem%3A+Trending+Content&utm_medium=trueAnthem&utm_source=
twitter
When is @CPHO_Canada stepping down as Ms. Tam is not up to any challenge when it comes to protecting the healthcare system?
1. Healthcare - https://www.slideshare.net/paulyoungcga/race-for-covid19-vaccines-and-treatments or
https://www.slideshare.net/paulyoungcga/reforming-healthcare
2. PPE Supply - https://news.ontario.ca/opo/en/2020/08/ontario-partners-with-federal-government-and-3m-canada-on-new-n95-respirator-
manufacturing-facility.html
3. People are still entering Canada from hot spots despite saying the border was closed -
https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2410000301
4. Migrant program and disease management audit - https://www.thestar.com/business/2020/08/20/migrant-worker-program-
to-undergo-federal-audit-following-massive-covid-19-outbreaks-on-canadian-farms.html
5. Health Canada and drug issues - https://www.ottawamatters.com/national-news/talks-needed-on-decriminalizing-hard-drugs-to-address-
opioid-crisis-tam-says-2657216
6. Quebec and Contract tracing - https://www.halifaxtoday.ca/national-news/quebec-wont-ask-population-to-use-covid-19-contact-tracing-
smartphone-app-2663902 - Quebec is concern with privacy issues
7. Airport Testing/Traveling - https://nationalpost.com/news/canada/hundreds-of-thousands-of-travellers-at-toronto-pearson-to-be-tested-for-
covid-19-in-early-2021
8. Funding to Education - https://globalnews.ca/news/7298419/feds-2-billion-school-coronavirus/ - Education is a provincial issue -

32. DONALD TRUMP AND PANDEMIC
 Travel restrictions - https://www.bbc.com/news/world-us-canada-51846923
 Pandemic funding - https://home.treasury.gov/policy-issues/cares CARES act was held up by Nancy Pelosi -
https://www.foxnews.com/politics/mccarthy-blames-pelosi-wish-list-coronavirus-stimulus-bill
 State and local funding - https://www.mckinsey.com/industries/public-and-social-sector/our-insights/us-
coronavirus-relief-funds-a-guide-for-state-and-local-governments
 Assisted living - https://www.whitehouse.gov/briefings-statements/president-donald-j-trump-is-taking-
decisive-action-to-protect-vulnerable-citizens-in-americas-nursing-homes/
 Blood treatment - https://globalnews.ca/news/7293522/donald-trump-fda-deep-state-coronavirus-vaccine/

33. CDC / DEATHS
Source - https://local12.com/news/nation-world/cdc-94-of-covid-19-deaths-had-underlying-medical-conditions-coronavirus-centers-for-disease-control or
https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm?fbclid=IwAR3-wrg3tTKK5-9tOHPGAHWFVO3DfslkJ0KsDEPQpWmPbKtp6EsoVV2Qs1Q or
https://nbc25news.com/news/local/cdc-94-of-covid-19-deaths-had-underlying-medical-conditions

34. HEALTHCARE SURVEILLANCE
Source - https://nationalpost.com/news/politics/canada-spent-147m-on-a-public-health-surveillance-system-that-isnt-being-used-during-covid-pandemic/wcm/e14f04a1-5314-4c55-a883-
57eeacd3b3e1/
• This was even a Liberal system brought in by Paul Martin

35. TRAVEL / CANADA
Source - https://www150.statcan.gc.ca/n1/daily-quotidien/200916/dq200916e-cansim-eng.htm

36. FISCAL MANAGEMENT
https://www.bnnbloomberg.ca/federal-deficit-hit-170-5b-through-august-on-emergency-spending-1.1515602
“Speaking to the Montreal Chamber of Commerce this morning, Freeland says the spending may seem enormous, but doing
any less would cost the country much more economically.
No mentioned of stimulus in many cases was poorly targeted
My work https://www.slideshare.net/paulyoungcga/fiscal-management-canada-october-2020

37. NO LOCKDOWN
Source -
https://eur04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fp.feedblitz.com%2Fr3.asp%3Fl%3D173343217%26f%3D64651%26c%3D0%26u%3D15561131&data=02%7C01%7C%7Cfc632a000624411046bd08d86e72a649%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637380785975473172&sdata=KNql94
1j%2BqzPgI8k2HkpS2avk7%2Ba4y6eb4xjBjZbUy8%3D&reserved=0
• All levels of government need to have risk
and crisis management plans -
https://www.slideshare.net/paulyoungcga/
how-to-implement-crisis-management-
using-data-and-ai
• The world needs to have performance
audits of all organizations like WHO -
https://www.slideshare.net/paulyoungcga/
internal-audit-and-governance-modeling-
public-and-private-sector

38. WHO / TEDROS
@DrTedros has history of coverups https://www.theglobeandmail.com/world/article-questions-surfacing-about-
history-of-whos-director-tedros-adhanom/ or https://www.orfonline.org/expert-speak/dr-cover-up-tedros-adhanoms-
controversial-journey-to-the-who-65493/
The WHO also needs to be reformed - https://www.slideshare.net/paulyoungcga/reforming-both-the-united-
nations-and-who

39. CORONAVIRUSES
Source - https://www.cdc.gov/coronavirus/types.html
• 229E (1960s) -
https://www.atsjournals.org/doi/full/10.1164/rccm.201506-
1239LE
• NLG63 – (1960s) -
https://www.atsjournals.org/doi/full/10.1164/rccm.201506-
1239LE
• OC43 – common cold -
https://academic.oup.com/cid/article/36/8/985/449256
• HKU1 -
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374449/
• SARS and other viruses never shutdown the economy
• Global Economy could take years to recovered -
https://www.slideshare.net/paulyoungcga/what-is-
next-for-the-global-economy-october-2020
• There is job crisis in Canada as well as around the
world -
https://www.slideshare.net/paulyoungcga/pandem
ic-and-covid19-canada-and-the-world
• More needs to be done to protect healthcare and
those most vulnerable -
https://www.slideshare.net/paulyoungcga/how-
do-you-fixed-assisted-living

40. CLINICAL TRIALS – COVID19 VACCINES
 Canada - https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-
treatments/list-authorized-trials.html
 USA - https://www.nih.gov/news-events/news-releases/nih-begins-large-clinical-trial-test-immune-modulators-
treatment-covid-19
 J&J pause - https://www.jnj.com/our-company/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-
vaccine-candidate-clinical-trials
 Vaccines - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-treatments-for-
covid-19
 Vaccines (October 31 to November 7, 2020)
 Nature - https://www.nature.com/articles/d41586-020-00502-w
 Vaccines - https://www.biopharmadive.com/news/coronavirus-vaccine-pipeline-types/579122
 Vaccines (W/E - December 6, 2020 )
 Vaccines - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-treatments-for-covid-19#COVID-19-
vaccines
 WHO - https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-
153-billion-in-2020-21

41. LATEST – PANDEMIC – COVID19
 Vaccines timeline - https://www.healthline.com/health-news/heres-exactly-where-were-at-with-vaccines-and-
treatments-for-covid-19#COVID-19-vaccines
 Vaccines and world economy - https://www.wsj.com/articles/a-covid-19-vaccine-would-boost-the-global-
economy-but-not-all-at-once-11605087345
 World Meter - https://www.worldometers.info/coronavirus/
 Elon Musk testing both positive and negative for COVID19 https://www.wsj.com/articles/tesla-ceo-elon-musk-
says-he-tested-both-positive-and-negative-for-covid-19-11605251724
 Testing Kits - https://www.ehstoday.com/health/article/21129419/fda-authorizes-athome-covid19-tests

42. VACCINATION TRACKING
Source - https://www.ctvnews.ca/health/coronavirus/covid-19-vaccine-tracker-how-many-people-in-canada-have-received-shots-
1.5247509 or https://ourworldindata.org/grapher/covid-vaccination-doses-per-
capita?tab=chart&stackMode=absolute&time=latest&region=World

43. VACCINES
 Pfizer - https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-
3-study-covid-19-vaccine
 Moderna - https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-
candidate-meets-its-primary-efficacy

44. STORAGE / VACCINES
You are asking for more than @CPHO_Canada and @PattyHajdu are willing to give in terms of information
1. Cold Storage - https://ca.finance.yahoo.com/news/cold-chain-throws-cold-water-over-pfizer-vaccine-hopes-
133716649.html
2. Supply/Market - https://www.grandviewresearch.com/industry-analysis/biomedical-refrigerators-and-freezers-market
3. Dry Ice - https://www.marketwatch.com/press-release/global-dry-ice-market-size-in-2020-industry-demand-market-
share-trend-industry-news-business-growth-top-key-players-top-countries-analysis-and-outlookshowing-impressive-
growth-by-2026-2020-09-03
My work on the pandemic - https://www2.slideshare.net/paulyoungcga/crisis-management-pandemic-covid19
Source - https://globalnews.ca/video/7470702/coronavirus-otoole-questions-trudeau-on-freezer-
capacity-for-possible-covid-19-vaccine

45. LATEST ON COVID19
 Vaccine reset - https://www.statnews.com/2020/10/29/it-may-be-time-to-reset-expectations-on-when-well-
get-a-covid-19-vaccine/
 Latest on vaccines - https://www.nationalgeographic.com/science/health-and-human-body/human-
diseases/coronavirus-vaccine-tracker-how-they-work-latest-developments-cvd/
 PPE Supply - https://www.modernhealthcare.com/supply-chain/hospitals-say-theyre-better-prepared-ppe-
spring-supply-chain-uncertain
 Reforming Healthcare - https://www.hfma.org/topics/hfm/2020/november/reimagining-the-healthcare-
supply-chain-to-bolster-resilience-an.html

46. REFORMING HEALTHCARE - DIGITAL HOSPITAL
https://www.canadianmanufacturing.com/technology/covid-19-sparks-boom-in-digital-hospitals-with-smart-technologies-
improving-quality-of-care-262683/
“COVID-19 sparks boom in digital hospitals with smart technologies, improving quality of care”
I have written many blogs on the transformation of healthcare https://www.slideshare.net/paulyoungcga/how-does-the-
world-transform-healthcare-238832381

47. COVID19 WILL HELP TRANSFORM HEALTHCARE
 https://www.cfo.com/health-benefits/2020/10/7-ways-covid-19-will-transform-health-
care/?utm_campaign=CFODailyAlert&utm_nooverride=1&utm_source=CFO-
email&utm_medium=email&utm_content=CFODailyAlert_Wednesday_2020-10-14&utm_term=health-benefits
Great Article with focus on the following areas:
1. Rise of Virtual Care
2. New digital approaches to meeting mental health needs
3. More entrepreneurial health care startups
4. Provider consolidation
5. More govt involvement
6. Increase in price sensitivity
7. Easing of regulation
My analysis - https://www.slideshare.net/paulyoungcga/how-does-the-world-transform-healthcare-238832381

48. GLOBAL ECONOMY
 Many businesses are more prepared for future geopolitical events. The use of AI and Analytics as part of the close, consolidate, and reporting
cycle is helping businesses better manage risk - https://www.slideshare.net/paulyoungcga/understanding-risks-as-part-of-development-risk-
management-best-practices
 Progressive need to stop pushing the global climate agenda as part of their various countries reset -
https://www.slideshare.net/paulyoungcga/clean-technology-and-the-green-economy-what-is-next
 There are many risks to the world economy - https://www.imf.org/en/Publications/WEO/Issues/2020/09/30/world-economic-outlook-october-
2020
 Businesses are pushing back - https://www.talentcanada.ca/ontario-restaurants-ask-province-to-explain-restrictions-show-covid-19-data/
Other Sources
 G7 - https://www.slideshare.net/paulyoungcga/what-is-next-for-g7-countries
 Circular Economy - https://www.slideshare.net/paulyoungcga/how-to-best-support-a-circular-economy
 Global - https://www.slideshare.net/paulyoungcga/what-is-next-for-the-global-economy-september-2020
 Canada GDP / August 2020 - https://www.slideshare.net/paulyoungcga/gdp-canada-august-2020
 Macros and Micro Indicators - https://www.slideshare.net/paulyoungcga/liberal-party-of-canada-fiscal-and-economic-scorecard-august-2020-
and-september-2020

49. CASES AND DEATH
Source -
https://www.nbc.ca/en/rates-and-
analysis/economic-analysis.html

50. WORLD-WIDE
DEATHS
Source - -
https://www.nbc.ca/en/rates-and-
analysis/economic-analysis.html

51. STORAGE
Vaccines freezing market –
1. Cold Storage - https://ca.finance.yahoo.com/news/cold-chain-throws-cold-water-over-pfizer-vaccine-hopes-
133716649.html
2. Supply/Market - https://www.grandviewresearch.com/industry-analysis/biomedical-refrigerators-and-freezers-
market
3. Dry Ice - https://www.marketwatch.com/press-release/global-dry-ice-market-size-in-2020-industry-demand-
market-share-trend-industry-news-business-growth-top-key-players-top-countries-analysis-and-outlookshowing-
impressive-growth-by-2026-2020-09-03
My work on the pandemic - https://www2.slideshare.net/paulyoungcga/crisis-management-pandemic-covid19

52. VACCINE PRODUCTION
@JustinTrudeau was told months ago there were issues of manufacturing vaccines (see CBC / Article on August 2, 2020) -
https://www.cbc.ca/news/health/covid-19-vaccine-countries-world-1.5668835
What did Trudeau do? Trudeau prorogue parliament for weeks on August 18, 2020 -
https://globalnews.ca/news/7283685/trudeau-prorogues-parliament-explained/
It seems the only time Trudeau responses to issues when the problem becomes a mountain!
My work - https://www2.slideshare.net/paulyoungcga/biotech-and-pharmaceutical-november

53. HOW TO PROVIDE BETTER TESTING AND ANALYTICS TO SUPPORT
MITIGATION OF COVID19 IMPACTS ON HEALTH OF PEOPLE AND THE
ECONOMY
 Failure rates with testing - https://www.slashgear.com/bombshell-cdc-report-reveals-1-in-3-early-covid-19-tests-failed-06646082/
 Testing/failures - https://www.npr.org/2020/11/06/929078678/cdc-report-officials-knew-coronavirus-test-was-flawed-but-released-it-anyway
 Test results / Elon Musk - https://www.newswise.com/factcheck/elon-musk-s-claim-that-covid-testing-is-bogus-is-not-accurate/?article_id=741919&fc=politics_channel
 False Positive tests - https://www.fda.gov/medical-devices/letters-health-care-providers/potential-false-positive-results-antigen-tests-rapid-detection-sars-cov-2-letter-
clinical-laboratory
 False Positive tests - https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30453-7/fulltext
 Failed test kits - https://www.blacklocks.ca/order-2m-kits-before-testing/
 Businesses need to be compensating for adjusting to the new normal - https://www2.slideshare.net/paulyoungcga/new-normal-for-canada-and-the-
world
 Auditing all models by auditor generals and 3rd party accounting firms - https://www2.slideshare.net/paulyoungcga/internal-audit-and-performance-
base-auditing
 More robust systems needs to be used to managed COVID19
 SQl/Data warehouse using analytical tools - https://www.mckinsey.com/business-functions/mckinsey-analytics/our-insights/leaderships-role-in-fixing-the-analytics-models-
that-covid-19-broke#
 More focus on mitigation including protecting those most vulnerable as well as allowing businesses to open using a reporting system
 SQL data base / testing of employees

54. VACCINES /
ORDERS
Source -
https://www.weforum.org/agend
a/2020/11/countries-vaccines-
covid-coronavirus-pandemic-
moderna-pfizer-astrazeneca-
covax-who/

55. VACCINE TRACKING / DOSAGE
 How will government keep track of the vaccination - https://www.verywellhealth.com/tracking-covid-19-
vaccine-recipients-5090661
 The vaccine, made by Pfizer Inc. and BioNTech SE, could be given to frontline health-care workers within days.
The U.S. plans to distribute 2.9 million doses in the first round of shipments. The vaccine has also been
approved in the U.K. and Canada, and a separate shot from Moderna Inc. is likely to follow. By the end of 2020,
millions of people could be inoculated. Next year: billions more.https://www.bloomberg.com/graphics/covid-
vaccine-tracker-global-distribution/
 GPS/Priorities - https://www.cnbc.com/2020/12/10/gps-tracking-priority-landing-special-treatment-for-
coronavirus-vaccines-fedex-ups.html

56. VACCINES ROLLOUT
Source - https://www.visualcapitalist.com/tracking-covid-19-vaccines-around-the-world/

57. VACCINE / SHOTS
Source - https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/

58. FLU CASES
Source - https://www.nature.com/articles/d41586-020-03519-3
That might partly have been an artefact caused by fewer people coming to a clinic for testing, experts say, but
it was also attributable to the effectiveness of policies such as social distancing. After the pandemic started,
positive tests for the flu virus plummeted by 98% in the United States, for example, whereas the number of
samples submitted for testing dropped by only 61%1. In the end, the US 2019–20 flu season was rated as
‘moderate’ by the CDC, which estimates that 38 million people fell ill with influenza, and 22,000 people died.
That’s fewer than in recent years, but not unprecedented.
After the flu season in the north ended early, it hardly got going at all in the Southern Hemisphere. There were
astonishingly few cases of seasonal flu there from April to July 2020 — even as global COVID-19 cases
continued to climb. In Australia, Chile and South Africa, a grand total of just 51 cases of flu were spotted in
more than 83,000 tests1. “We know it’s less transmissible than coronavirus, so it makes sense,” says Olsen, but
the decline was still “greater than expected”. Influenza’s absence has been attributed to pandemic-response
measures, but they don’t tell the whole story.
“Some South American countries haven’t done such a good job controlling COVID, but even there flu is low,”
says virologist Richard Webby at St Jude’s hospital in Memphis, Tennessee. “I don’t think we can put it all down
to mask wearing and social distancing.” He suspects that the dearth of international travel played a part. Flu
typically travels around the world from one winter to another, while maintaining a lower year-round presence
in the tropics.

59. TRAINING AND DEVELOPMENT
 If you like to learn more
about trade and/or other
subjects as part of your
professional learning and
development then feel free
to review my material on
https://www.udemy.com/
(search Paul Young CPA
CGA)
 These subjects address how
to fixed issues with housing
and/or systemic issues
related to economy
including government
policies

60. SUMMARY
 There are many companies involved with research and development of COVID19 vaccine -
https://www.scienceboard.net/index.aspx?sec=sup&sub=imm&pag=dis&ItemID=677
 Bill and Melinda Gates Foundation are playing a key role with funding and manufacturing -
https://www.geekwire.com/2020/gates-foundation-commits-50m-covid-19-vaccine-initiative-
total-funding-now-tops-300m/ (Funding is now over $300M (USD)
 There are allot of startups involved. Various Canadian governments have been funding VC
companies related to biotech research
 There appears to be lack of progress reports on the state of affairs when it comes to
government money going to vaccinations R&D -
https://cmajnews.com/2020/05/20/coronavirus-1095847/
 There is allot of speculator investments going on with biotech companies as part of reaping the
rewards when vaccines go to market.
 Major pharma continues to work with government, institution, labs, Tech, etc.
https://www.bioworld.com/articles/435263-astrazeneca-moving-at-warp-speed-with-12b-in-
barda-funding-for-covid-19-vaccine
 Medical Products - https://www.dailymail.co.uk/health/article-8717013/Scarcity-key-material-
squeezes-medical-mask-manufacturing.html
 Economy could see periods of slow growth for years -
https://www.slideshare.net/paulyoungcga/transforming-the-economy-postcovid19-canada-
and-the-world or https://www.investmentexecutive.com/news/research-and-markets/covid-19-
to-reshape-economy-society-moodys/ or https://www.slideshare.net/paulyoungcga/gdp-
canada-may-2020 or https://www.slideshare.net/paulyoungcga/global-economy-current-state-
and-whats-next
 Adopting Risk Analytics and Crisis Management policies and procedures including annual audits
- https://www2.slideshare.net/paulyoungcga/how-best-to-managed-a-geoplitical-crisis-crisis-
management